TraceLink Announces Appointment of George Llado, former Merck and Alexion CIO, to Board of Directors
Retrieved on:
Thursday, May 18, 2023
National Center for Telecommunications Technologies, Lladó, Senior, Information technology, Temple University, Schering-Plough, Health care, Sierra Ventures, National Center for Women & Information Technology, Supplier performance management, Merck & Co., Alexion Pharmaceuticals, Patient, Supply chain, Alexion, CIO, Growth, Commercial, Rare, Temple University Hospital, Woman, Safety, Fine chemical, Cryptocurrency, Pharmaceutical industry, Management, Pharma, Merck
BOSTON, May 18, 2023 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000 entities across the Healthcare and Life Sciences industry, today announced the appointment of George Llado to the TraceLink Board of Directors.
Key Points:
- BOSTON, May 18, 2023 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000 entities across the Healthcare and Life Sciences industry, today announced the appointment of George Llado to the TraceLink Board of Directors.
- "After spending more than a decade as a customer that depended on TraceLink's mission critical traceability and serialization solutions," said Llado, "I am delighted to join TraceLink's Board of Directors.
- In addition to this appointment, he serves on the Board of Charles River Laboratories and The National Center for Women & Information Technology.
- "George has been an esteemed customer and partner of TraceLink from day one," said Shabbir Dahod, President and CEO at TraceLink.